177 related articles for article (PubMed ID: 38204601)
1. SiRNF8 Delivered by DNA Framework Nucleic Acid Effectively Sensitizes Chemotherapy in Colon Cancer.
Guo Z; Song H; Tian Y; Xu J; Zhang G; Guo Y; Shen R; Wang D
Int J Nanomedicine; 2024; 19():171-188. PubMed ID: 38204601
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of autophagy enhances apoptosis induced by doxorubicin hydrochloride in human colon cancer cells].
Tang H; Wu D; Yang H; Yang J; Zhang Y; Li M; Liu H; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Mar; 38(3):237-243. PubMed ID: 35365989
[TBL] [Abstract][Full Text] [Related]
3. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
[TBL] [Abstract][Full Text] [Related]
4. Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging.
Kalimuthu S; Zhu L; Oh JM; Lee HW; Gangadaran P; Rajendran RL; Baek SH; Jeon YH; Jeong SY; Lee SW; Lee J; Ahn BC
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584688
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
[TBL] [Abstract][Full Text] [Related]
7. Framework Nucleic Acid-Based Multifunctional Tumor Theranostic Nanosystem for miRNA Fluorescence Imaging and Chemo/Gene Therapy.
Luo H; Wang Z; Mo Q; Yang J; Yang F; Tang Y; Liu J; Li X
ACS Appl Mater Interfaces; 2023 Jul; 15(28):33223-33238. PubMed ID: 37421332
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment.
Hu C; Gu F; Gong C; Xia Q; Gao Y; Gao S
J Biomater Appl; 2022 Feb; 36(7):1317-1331. PubMed ID: 34856824
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein.
Wang H; Deng Z; Chen X; Cai J; Ma T; Zhong Q; Li R; Li L; Li T
Med Sci Monit; 2019 Mar; 25():2169-2178. PubMed ID: 30904920
[TBL] [Abstract][Full Text] [Related]
10. Highly stable near-infrared dye conjugated cerasomes for fluorescence imaging-guided synergistic chemo-photothermal therapy of colorectal cancer.
Zhang X; Liang X; Ma X; Hou R; Li X; Wang F
Biomater Sci; 2019 Jul; 7(7):2873-2888. PubMed ID: 31070203
[TBL] [Abstract][Full Text] [Related]
11. Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin.
Yao F; An Y; Li X; Li Z; Duan J; Yang XD
Int J Nanomedicine; 2020; 15():2119-2129. PubMed ID: 32280210
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
13. Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy.
Zhang P; Li J; Ghazwani M; Zhao W; Huang Y; Zhang X; Venkataramanan R; Li S
Biomaterials; 2015 Oct; 67():104-14. PubMed ID: 26210177
[TBL] [Abstract][Full Text] [Related]
14. USP10 suppresses ABCG2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway.
Sun J; Xiang Q; Ding D; Yan N
J Bioenerg Biomembr; 2023 Dec; 55(6):457-466. PubMed ID: 37919637
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells.
Sesarman A; Tefas L; Sylvester B; Licarete E; Rauca V; Luput L; Patras L; Banciu M; Porfire A
Pharmacol Rep; 2018 Apr; 70(2):331-339. PubMed ID: 29477042
[TBL] [Abstract][Full Text] [Related]
16. Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles.
Vong LB; Nagasaki Y
Mol Pharm; 2016 Feb; 13(2):449-55. PubMed ID: 26605906
[TBL] [Abstract][Full Text] [Related]
17. Aptamer-Functionalized DNA Origami for Targeted Codelivery of Antisense Oligonucleotides and Doxorubicin to Enhance Therapy in Drug-Resistant Cancer Cells.
Pan Q; Nie C; Hu Y; Yi J; Liu C; Zhang J; He M; He M; Chen T; Chu X
ACS Appl Mater Interfaces; 2020 Jan; 12(1):400-409. PubMed ID: 31815420
[TBL] [Abstract][Full Text] [Related]
18. Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression.
Zhan M; Yu D; Lang A; Li L; Pollock RE
Cancer; 2001 Sep; 92(6):1556-66. PubMed ID: 11745235
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Evaluation of Doxorubicin-Loaded PLA-PEG-FA Copolymer Containing Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Cancer Treatment: Combination Therapy with Hyperthermia and Chemotherapy.
Khaledian M; Nourbakhsh MS; Saber R; Hashemzadeh H; Darvishi MH
Int J Nanomedicine; 2020; 15():6167-6182. PubMed ID: 32922000
[TBL] [Abstract][Full Text] [Related]
20. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]